Active Ingredient (Generic Name) | Cisplatin (50mg) |
---|---|
Indication | Treatment of ovarian, cervical and testicular cancer. |
Manufacturer | Cipla Ltd |
Packaging | 1x1 |
Strength | 50 mg |
Delivery Time | 8 Days |
Cytoplatin is an injectable chemotherapy drug containing cisplatin, a platinum-based compound widely used to treat several types of cancer, including ovarian cancer, testicular cancer, bladder cancer, lung cancer, cervical cancer, and head and neck cancers. Cisplatin works by disrupting the DNA of cancer cells, preventing them from multiplying and leading to cell death.
Cytoplatin is usually part of combination chemotherapy regimens and is administered in a hospital or clinic setting by trained medical professionals.
✅ Testicular Cancer — Forms the backbone of curative regimens, often combined with etoposide and bleomycin (BEP regimen).
✅ Ovarian Cancer — Used in first-line treatment and relapsed disease.
✅ Bladder Cancer — Standard treatment for advanced or metastatic disease.
✅ Non-Small Cell Lung Cancer (NSCLC) — Combined with other agents in first-line therapy.
✅ Cervical Cancer — Often used with radiotherapy for enhanced tumor control.
✅ Head and Neck Cancers — Used alongside radiation therapy in locally advanced cases.
Effective against multiple cancers: Especially platinum-sensitive tumors like testicular and ovarian cancer.
Synergistic action: Enhances the effect of other chemotherapeutic drugs.
Well-established survival benefit: Extensively studied in clinical trials with proven efficacy.
Hospital-administered: Ensures careful dosing, hydration, and monitoring.
Cytoplatin is an injectable chemotherapy drug containing cisplatin, a platinum-based compound widely used to treat several types of cancer, including ovarian cancer, testicular cancer, bladder cancer, lung cancer, cervical cancer, and head and neck cancers. Cisplatin works by disrupting the DNA of cancer cells, preventing them from multiplying and leading to cell death.
Cytoplatin is usually part of combination chemotherapy regimens and is administered in a hospital or clinic setting by trained medical professionals.
✅ Testicular Cancer — Forms the backbone of curative regimens, often combined with etoposide and bleomycin (BEP regimen).
✅ Ovarian Cancer — Used in first-line treatment and relapsed disease.
✅ Bladder Cancer — Standard treatment for advanced or metastatic disease.
✅ Non-Small Cell Lung Cancer (NSCLC) — Combined with other agents in first-line therapy.
✅ Cervical Cancer — Often used with radiotherapy for enhanced tumor control.
✅ Head and Neck Cancers — Used alongside radiation therapy in locally advanced cases.
Effective against multiple cancers: Especially platinum-sensitive tumors like testicular and ovarian cancer.
Synergistic action: Enhances the effect of other chemotherapeutic drugs.
Well-established survival benefit: Extensively studied in clinical trials with proven efficacy.
Hospital-administered: Ensures careful dosing, hydration, and monitoring.